Alaska Permanent Fund’s Bristol-Myers Squibb BMY Stock Holding History

Alaska Permanent Fund’s Portfolio BMY Stock Details BMY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-34,971	Closed	-$1.76M	–	60
2025 Q1	$1.76M	Hold	34,971	–	–	0.02%	296
2024 Q4	$1.98M	Hold	34,971	–	–	0.03%	291
2024 Q3	$1.81M	Hold	34,971	–	–	0.03%	320
2024 Q2	$1.66M	Sell	34,971 -92,024	-72%	-$4.12M	0.02%	326
2024 Q1	$6.89M	Sell	126,995 -122,211	-49%	-$6.23M	0.1%	93
2023 Q4	$12.8M	Sell	249,206 -45,855	-16%	-$2.41M	0.21%	47
2023 Q3	$17.1M	Buy	295,061 +2,773	+0.9%	+$170K	0.32%	31
2023 Q2	$18.7M	Buy	+292,288	New	+$19.6M	0.37%	30
2022 Q4	$13M	Buy	180,249 +2,895	+2%	+$218K	0.21%	33
2022 Q3	$12.6M	Buy	177,354 +29,406	+20%	+$2.13M	0.23%	23
2022 Q2	$11.4M	Buy	147,948 +108,134	+272%	+$8.24M	0.16%	32
2022 Q1	$2.91M	Buy	39,814 +814	+2%	+$54.7K	0.05%	71
2021 Q4	$2.53M	Hold	39,000	–	–	0.05%	119
2021 Q3	$2.31M	Hold	39,000	–	–	0.05%	153
2021 Q2	$2.61M	Buy	39,000 +400	+1%	+$26.1K	0.05%	53
2021 Q1	$2.44M	Hold	38,600	–	–	0.04%	195
2020 Q4	$2.39M	Hold	38,600	–	–	0.04%	182
2020 Q3	$2.33M	Buy	38,600 +18,920	+96%	+$1.14M	0.04%	49
2020 Q2	$1.16M	Hold	19,680	–	–	0.02%	44
2020 Q1	$1.1M	Buy	+19,680	New	+$1.2M	0.02%	37

Other funds holding BMY

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Alaska Permanent Fund's BMY Position: Q2 2025 in Review

Alaska Permanent Fund sold out of Bristol-Myers Squibb (BMY) in Q2 2025, closing a stake of 34,971 shares — an estimated $1.76M sold.

Alaska Permanent Fund first reported a position in BMY in Q1 2020 and held it in 20 quarters. The position peaked at $18.7M in Q2 2023. 2,300 funds tracked by Wall St. Rank hold BMY as of Q2 2025.

Alaska Permanent Fund reported no remaining Bristol-Myers Squibb position as of Q2 2025 after selling out during the quarter.
Alaska Permanent Fund sold 34,971 Bristol-Myers Squibb shares in Q2 2025, an estimated $1.76M.
Alaska Permanent Fund first reported a position in Bristol-Myers Squibb in Q1 2020 and held it in 20 quarters.
Alaska Permanent Fund's Bristol-Myers Squibb position peaked at $18.7M in Q2 2023.
2,300 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2025.

Based on Alaska Permanent Fund's 13F filing for Q2 2025, filed 14 Aug 2025.